United States· US:55111-256_7eaaea2d-4068-4a22-c7f5-c4ac01d418a1
ziprasidone
A ziprasidone product containing ziprasidone, registered in United States by Dr. Reddy's Laboratories Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Ziprasidone is registered in 14 of 19 countries.
Countries holding a registration under ATC N05AE04 (ziprasidone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Ziprasidone · ATC N05AE04
14 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ziprasidone costs, country by country.
Normalised to the WHO defined daily dose (80 mg), so markets compare like for like.
- United States: $0.54 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Ziprasidone · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- US United States$0.54 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ziprasidone
- Manufacturer
- Dr. Reddy's Laboratories Limited
- Country
- United States (US)
- ATC code
- N05AE04
- ATC class
- Ziprasidone
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 7
- ndc115511125601100 CAPSULE in 1 BOTTLE (55111-256-01)
- ndc115511125605500 CAPSULE in 1 BOTTLE (55111-256-05)
- ndc11551112563030 CAPSULE in 1 BOTTLE (55111-256-30)
- ndc11551112566060 CAPSULE in 1 BOTTLE (55111-256-60)
- ndc11551112567810 BLISTER PACK in 1 CARTON (55111-256-78) / 10 CAPSULE in 1 BLISTER PACK
- ndc1155111256813 BLISTER PACK in 1 CARTON (55111-256-81) / 10 CAPSULE in 1 BLISTER PACK
- ndc11551112569090 CAPSULE in 1 BOTTLE (55111-256-90)
Regulatory notes
Interactions
403 interactions on record for ziprasidone.
Graded by severity as the source publishes them — 147 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ziprasidone · interactions on record
403 records
- 147 severe
- 162 moderate
- 38 minor
- 56 info
Most severe, free to view
- PapaverineA03AD01severe
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ziprasidone in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainZELDOX 20 mg CAPSULAS DURASViatris Healthcare Limited
- SwedenZeldox 20 mg Kapsel, hårdViatris Healthcare Limited
- FinlandZeldoxViatris Healthcare Limited
- IcelandZeldoxViatris ApS
- IrelandGeodon 20mg capsules, hardViatris Healthcare Limited
- CanadaAURO-ZIPRASIDONEAURO PHARMA INC
- PolandZypsilaKrka, d.d., Novo mesto
- NorwayZiprasidon ActavisActavis Group PTC ehf
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Zeldox, Ziprasidon Krka
- Bulgaria · Зелдокс, Зипсила
- Cyprus · Geodon
- Czechia · Zeldox, Zypsilan
- Germany · Zeldox, Ziprasidon 1 A Pharma
- Denmark · Zeldox, Ziprasidon Krka
- Spain · Zeldox, Ziprasidona Aurovitas
- Finland · Zeldox, Ziprasidon Krka
- Greece · Geodon, Ziprasidone Actavis
- Croatia · Zeldox
- Hungary · Ypsila, Zeldox
- Ireland · Geodon
- Iceland · Zeldox, Ziprasidon Actavis
- Italy · Zeldox, Ziprasidone Sandoz
- Lithuania · Zeldox, Zypsilan
- Latvia · Ypsila, Zeldox
- Malta · Ziprasidone Aurobindo
- Norway · Zeldox, Ziprasidon Actavis
- Poland · Zypsila
- Portugal · Zeldox, Ziprasidona Aurobindo
- Romania · Zypsila
- Sweden · Zeldox, Ziprasidon Actavis
- Slovenia · Zeldox, Zypsila
- Slovakia · Zeldox, Zipwell
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/add79b96-a7b0-4288-bdc4-519f68d3aaa7 GET /v1/drugs/add79b96-a7b0-4288-bdc4-519f68d3aaa7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "216X081ORU",
"rxcui": "284925",
"inchikey": "ZCBZSCBNOOIHFP-UHFFFAOYSA-N",
"display_name": "ZIPRASIDONE HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 4
},
"spl_meta": {
"7e7261d7-4902-4bb5-a268-6c358890f963": {
"match": "brand_token",
"title": "ZIPRASIDONE HYDROCHLORIDE CAPSULE [REMEDYREPACK INC.]",
"spl_version": "18",
"published_date": "2026-05-25"
}
},
"productid": "55111-256_7eaaea2d-4068-4a22-c7f5-c4ac01d418a1",
"productndc": "55111-256",
"dosage_form": "CAPSULE",
"orange_book": {
"appl_no": "077565",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 20MG BASE",
"product_no": "001",
"approval_date": "Mar 2, 2012"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 40MG BASE",
"product_no": "002",
"approval_date": "Mar 2, 2012"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 60MG BASE",
"product_no": "003",
"approval_date": "Mar 2, 2012"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 80MG BASE",
"product_no": "004",
"approval_date": "Mar 2, 2012"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ZIPRASIDONE HYDROCHLORIDE",
"proprietary_name": "ziprasidone",
"active_ingred_unit": "mg/1",
"application_number": "ANDA077565",
"marketing_category": "ANDA",
"nonproprietary_name": "ziprasidone",
"start_marketing_date": "20120302",
"active_numerator_strength": "20"
}See everything about ziprasidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.